|
|
|
ALXN Alexion Pharmaceuticals, Inc. Research
|
ALXN: Soliris, solipsis...all the same to me! |
|
Opened $71.53 1/3/12
Target $84.00 (+17.4%) by 7/12/12
Made 35.9%
|
...at least for now. This is my first coverage of 2012, and it's time to come roaring back from the doldrums that hit me in late 2011. I took most of the fall off, so I'm a bit rusty, but I tended to have decent luck with my pharma picks, so I'm kicking off this new year with a company whose sole drug (as of... continue
|
|